Ulta Lab Tests

Prothrombin (Factor II) 20210G->A Mutation Analysis

The Prothrombin (Factor II) 20210G→A Mutation Analysis Test detects a genetic variant in the prothrombin gene linked to increased risk of abnormal blood clotting. This mutation is associated with venous thromboembolism, deep vein thrombosis, and pulmonary embolism. Identifying this mutation helps evaluate inherited thrombophilia, supporting risk assessment, family studies, and management of clotting disorders.

Blood
Phlebotomist
There are no preparation instructions.

The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.

Specimen Type: Blood

Also known as: Prothrombin Factor II 20210GA Mutation Analysis

Interpretation

Prothrombin (Factor Ii)

*Important Information on Lab Test Processing Times: Ulta Lab Tests is committed to informing you about the processing times for your lab tests processed through a national lab. Please note that the estimated processing time for each test, indicated in business days, is based on data from the past 30 days across the 13 laboratories for each test. These estimates are intended to serve as a guide and are not guarantees. Factors such as laboratory workload, weather conditions, holidays, and the need for additional testing or maintenance can influence actual processing times. We aim to offer estimates to help you plan accordingly. Please understand that these times may vary, and processing times are not guaranteed. Thank you for choosing Ulta Lab Tests for your laboratory needs.

The Prothrombin (Factor II) 20210G->A Mutation Analysis test contains 1 test with 2 biomarkers .

Factor II Mutation (G20210A) is one of the most common causes of venous thrombosis. 2.3% of the general population is heterozygous in contrast with 6.2% of patients with venous thrombosis and 18% with familial venous thrombosis. Other risk factors compound the risk for venous thrombosis.

Customer Reviews